Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Follicular Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Yuting Yan) · yanyuting@ihcams.ac.cn · 13820706239
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, China
Contact: Study coordinator (Yuting Yan, Dr)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Basking Ridge, United States

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma · Follicular Lymphoma With Unusual Cytological Features

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Phoenix, United States

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States